Harvard Heart Letter

Trial renews surgery vs. stent debate

People with artery disease may have a choice between bypass surgery and angioplasty, depending on the circumstances of one's condition and other factors such as whether or not a person can take the medication clopidogrel.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In